Literature DB >> 12717626

Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.

Takashi Hiromatsu1, Toshiki Yajima, Tetsuya Matsuguchi, Hitoshi Nishimura, Worawidh Wajjwalku, Toshiyuki Arai, Yuji Nimura, Yasunobu Yoshikai.   

Abstract

Interleukin (IL)-15, a potent inhibitor of tumor necrosis factor (TNF)-alpha-mediated apoptosis, causes multiple organ failure during endotoxic shock. We investigated the potential role of IL-15 in protection against Escherichia coli-induced shock by using IL-15 transgenic (Tg) mice. These mice were resistant to an otherwise lethal challenge with E. coli, although bacterial burden and serum levels of TNF-alpha were similar in non-Tg mice. Apoptosis in cells of the peritoneal cavity, liver, spleen, or lung was significantly suppressed in IL-15 Tg mice after E. coli infection. Peritoneal cells from naive IL-15 Tg mice were also resistant to TNF-alpha-induced apoptosis in vitro, and neutralization of endogenous IL-15 significantly aggravated TNF-alpha-induced apoptosis. Exogenous IL-15 prevented TNF-alpha-induced apoptosis in normal mice in vitro and improved the survival rate after E. coli challenge. These results suggest that IL-15 overexpression can prevent TNF-alpha-induced apoptosis and protect against E. coli-induced shock, indicating a possible therapeutic application of IL-15 for septic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717626     DOI: 10.1086/374643

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

2.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Authors:  Thomas A Stoklasek; Kimberly S Schluns; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

3.  The role of Interleukin 15 in protein degradation in skeletal muscles in rats of chronic obstructive pulmonary disease.

Authors:  Zhaohui Liu; Wei Fan; Jinlong Chen; Zhike Liang; Lijun Guan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis.

Authors:  Shigeaki Inoue; Jacqueline Unsinger; Christopher G Davis; Jared T Muenzer; Thomas A Ferguson; Katherine Chang; Dale F Osborne; Andrew T Clark; Craig M Coopersmith; Jonathan E McDunn; Richard S Hotchkiss
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

Review 5.  Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes.

Authors:  Jianping Ye
Journal:  Front Med       Date:  2014-12-15       Impact factor: 4.592

6.  Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.

Authors:  Georgia Perona-Wright; Katja Mohrs; Frank M Szaba; Lawrence W Kummer; Rajat Madan; Christopher L Karp; Lawrence L Johnson; Stephen T Smiley; Markus Mohrs
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

7.  Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction.

Authors:  Emanuele Marzetti; Christy S Carter; Stephanie E Wohlgemuth; Hazel A Lees; Silvia Giovannini; Barbara Anderson; LeBris S Quinn; Christiaan Leeuwenburgh
Journal:  Mech Ageing Dev       Date:  2009-04       Impact factor: 5.432

8.  Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues.

Authors:  Ali A Ashkar; Sarah Reid; Elena F Verdu; Kun Zhang; Brian K Coombes
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

9.  Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin.

Authors:  Toshiki Yajima; Hitoshi Nishimura; Kimika Saito; Hiroyuki Kuwano; Yasunobu Yoshikai
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats.

Authors:  Emidio E Pistilli; Stephen E Alway
Journal:  Biochem Biophys Res Commun       Date:  2008-06-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.